Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?

View ORCID ProfileKrzysztof Lukaszuk, Jolanta Kiewisz, Karolina Rozanska, Amira Podolak, Grzegorz Jakiel, Izabela Woclawek-Potocka, Lukasz Rabalski, Aron Lukaszuk
doi: https://doi.org/10.1101/2021.04.29.21256246
Krzysztof Lukaszuk
1Department of Obstetrics and Gynecology Nursing, Medical University of Gdansk, Gdansk, Poland
2Invicta Research and Development Center, Sopot, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Krzysztof Lukaszuk
Jolanta Kiewisz
3Department of Human Histology and Embryology, Medical Faculty, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karolina Rozanska
2Invicta Research and Development Center, Sopot, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amira Podolak
2Invicta Research and Development Center, Sopot, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grzegorz Jakiel
41st Department of Obstetrics and Gynecology, The Center of Postgraduate Medical Education, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Izabela Woclawek-Potocka
5Department of Gamete and Embryo Biology, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lukasz Rabalski
6Laboratory of Recombinant Vaccines Intercollegiate Faculty of Biotechnology University of Gdansk and Medical University of Gdansk, Gdansk, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aron Lukaszuk
41st Department of Obstetrics and Gynecology, The Center of Postgraduate Medical Education, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lukaszuk.aron@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The introduction of vaccination against SARS-CoV-2 infection needs precise instruments for quality control of vaccination procedure, detection of poor immunological response and estimation of the achieved protection against the disease but also against infection and being infective.

Objective To compare new automated SARS-CoV 2 Ig assay performance characteristics from the automated Elecsys SARS-CoV-2 S (Roche) with the new LIAISON® SARS-CoV-2 TrimericS IgG (DiaSorin) assay and their compatibility with WHO International Standard for anti-SARS-CoV-2 immunoglobulin. In the context of the mass vaccination programs, we undertook the investigation of clinical utility of the two new automated assays by analyzing results in samples collected at specified time points relative to the vaccination time.

Design Prospective assay evaluation.

Patients Medical staff undergoing vaccination with BioNTech/Pfizer Comirnaty vaccine between January and March 2021 (n = 79) and referred for serum antiSARS-CoV 2 Ig testing prior to vaccination, 21 days after the first dose, and 8, 14 and 30 days after the second dose. Main Outcome Measure(s): Serum antibody levels measured with Roche and DiaSorin assays.

Results Intra-assay imprecision was low with DiaSorin at 3.46%; and Roche at 2.5%. The Passing-Bablok regression equation for all tested samples was y (DiaSorin) = 184.61 + (1.03 x Roche) and the correlation between the assays (r=0.587; p < 0.0001).

Conclusions The novel automated assays exhibit strong concordance in calibration, with assay-specific interpretation required for routine clinical use. These results highlight the need for further work on the international standard of measurement of SARS-CoV 2 Ig especially in era of vaccination. The serological assays can be useful to detect IgG/IgM antibodies, to assess the degree of immunization, to trace the contacts, and to support the decision to readmit people to work or vaccinate them again. However, the values generated by both assays can be markedly different, and assay-specific and personalized interpretation is required.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study has been financed by Invicta Research and Development Center

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethical approval was received from the Ethics Committee at the Gdansk Regional Medical Board (No KB - 4/21)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

N/A

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 02, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
Krzysztof Lukaszuk, Jolanta Kiewisz, Karolina Rozanska, Amira Podolak, Grzegorz Jakiel, Izabela Woclawek-Potocka, Lukasz Rabalski, Aron Lukaszuk
medRxiv 2021.04.29.21256246; doi: https://doi.org/10.1101/2021.04.29.21256246
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
Krzysztof Lukaszuk, Jolanta Kiewisz, Karolina Rozanska, Amira Podolak, Grzegorz Jakiel, Izabela Woclawek-Potocka, Lukasz Rabalski, Aron Lukaszuk
medRxiv 2021.04.29.21256246; doi: https://doi.org/10.1101/2021.04.29.21256246

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1262)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10055)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)